Abstract
Background
Converting the transient spasticity-reducing effect of botulinum toxin A (BTX-A) into durable neuroplastic adaptations through mirror therapy (MT) represents a promising yet understudied approach. Although MT facilitates motor recovery, evidence on its long-term synergistic use with BTX-A in chronic stroke remains limited.
Aim
To investigate the synergistic effects of MT combined with BTX-A on upper limb spasticity and motor recovery in chronic ischemic stroke.
Design
Randomized, single-blind, sham-controlled clinical trial.
Methods and Population
Thirty patients with unilateral chronic ischemic stroke and upper limb spasticity were randomized into two groups following BTX-A injection. The experimental group received MT plus standard rehabilitation, while the control group underwent sham therapy using a transparent panel. Interventions began 2 weeks postinjection and were applied three times weekly for approximately 60 sessions over six months. Outcomes were assessed using Brunnstrom recovery stages, modified Ashworth scale (MAS), and Fugl–Meyer assessment for upper extremity (FMA-UE).
Results
Both groups showed significant within-group improvements in motor and spasticity scores (p < 0.001). Greater improvements were observed in the MT group for Brunnstrom hand (p = 0.021), Brunnstrom upper extremity (p = 0.029), MAS upper extremity (p = 0.012), and FMA-UE (p = 0.002). Muscle strength differences were not significant.
Conclusion
MT combined with BTX-A improves motor recovery and reduces spasticity more than BTX-A alone in chronic stroke, supporting cortical reorganization and neuromuscular relaxation as a cost-effective rehabilitation strategy.
Keywords
Get full access to this article
View all access options for this article.